Humacyte (HUMA) Competitor Comparison
We are evaluating the key criteria listed to compare Humacyte (HUMA) against its competitors in the Biotechnology industry.
Market Capitalization
174 / 368Gross Profits
0 / 278Total Revenue
294 / 300EBITDA
184 / 337Free Cashflow
207 / 352Quick Ratio
140 / 357Earnings per Share
163 / 359Dividend yield
0 / 6Total Cash
217 / 358Performance 3 years
169 / 368Performance 5 years
175 / 368Performance 10 years
148 / 368Linearity 3 years
150 / 368Linearity 5 years
110 / 368Linearity 10 years
105 / 368Total Rank
322 / 368Dividend Rank
148 / 368Valuation Rank
340 / 368Piotroski Rank
285 / 368Muliplier Rank
357 / 368Performance 3 years - HUMA ranking 169 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.